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CorrespondenceRiboswitch Regulation of
Aminoglycoside Resistance
Acetyl and Adenyl TransferasesIn our recent paper, we reported an
aminoglycoside-sensing RNA in the
leader RNA of the aminoglycoside acetyl
transferase (AAC) and aminoglycoside
adenyl transferase (AAD), enzymes that
confer resistance to aminoglycoside anti-
biotics through modification of the drugs.
Our study explains a well-known phe-
nomenon: the induction of expression
levels of the AAC/AAD proteins on addi-
tion of aminoglycosides (Williams and
Northrop, 1976). In this paper, we pre-
sented data that showed: (1) aminoglyco-
side-specific induction of reporter genes
mediated by the leader RNA of the AAC
in Pseudomonas fluorescens; (2) amino-
glycoside binding to the leader RNA by
surface plasmon resonance spectros-
copy (SPR); (3) that binding induces a
structural transition in the leader RNA
that can be detected by changes in gel
electrophoretic mobility and chemical
probing; (4) the identification of a specific
aminoglycoside-RNA crosslink; (5) con-
firmation, via mutational analysis, of the
main features of the RNA secondary
structure and the importance of structural
elements within it for drug binding.
We show these aspects of our study to
be internally consistent and complemen-
tary. The six 4,6 deoxystreptamine ami-
noglycosides that induce the reporter
gene bind well to the leader RNA by SPR
and cause a structural transition in the
RNA, as measured by chemical probing.
The three control molecules that do not
induce reporter gene expression bind
weakly to the leader RNA by SPR and
do not cause a structural transition in the
RNA by chemical probing. We have re-
porter assays, SPR, and chemical probing
data that are all in clear and good agree-
ment. In our view, these data are consis-
tent with a riboswitch model of regulation
for aac/aad genes.
In the accompanying Correspondence
in this issue ofCell, Roth and Breaker sug-
gest that the binding that we measure
reflects spurious electrostatic drug-RNAinteractions. However, the correlation
between the in vitro binding that we mea-
sure by SPR and the specificity of the
reporter gene induction argues against
this. Accordingly, the aminoglycosides
that bind weakly do not induce the re-
porter gene, whereas aminoglycosides
that bind with high affinity induce leader-
RNA-mediated reporter gene expression,
suggesting that the binding that we mea-
sure is biologically relevant. Moreover, in
reporter assays in which the leader RNA
of aac/aad is replaced by a different
leader RNA (cat-86), we no longer
observe induction of the reporter gene,
suggesting that the interaction between
inducing aminoglycosides and the leader
RNA of aac/aad is very specific. Addi-
tional roles are emerging for aminogly-
cosides as cellular modulators and
subinhibitory doses induce biofilm forma-
tion (Hoffman et al., 2005) and the bacte-
rial SOS response (Baharoglu and Mazel,
2011).
Roth and Breaker assert that ribos-
witches typically influence reporter gene
expression over a range of 10- to 1000-
fold, but this is only correct for some
riboswitches. A number of riboswitches
display lower levels of reporter gene
expression; for example, the adenine
binding add riboswitch (Lemay et al.,
2011) shows 3-fold induction and the
guanine riboswitch, 6.7-fold repression
(Mandal et al., 2003). Riboflavin represses
the FMN riboswitch 5-fold (Lee et al.,
2009), and the S-adenosyl methionine-
binding SMK riboswitch is repressed 2-
to 3-fold (Smith et al., 2010). Thus, the
levels of reporter gene expression
measured in solution in our reporter assay
are close to previously characterized
translational riboswitches and are consis-
tent with the translational riboswitch that
we propose. However, we initially mea-
sured reporter gene expression by agar
diffusion assays—a more sensitive assay
system inwhich induction of gene expres-
sion can be directly visualized on agarCell 15plates (Bailey et al., 2008). We consis-
tently observed clear induction of reporter
gene expression as blue rings on plates
by the inducing aminoglycosides and no
induction by the control drugs. This
method provides an independent confir-
mation of our solution-based reporter
gene expression measurements. Roth
and Breaker propose that aminoglyco-
sides work by targeting the ribosome to
change global protein production and
cause small changes in reporter gene
expression; this is not consistent with
the known mechanism of ribosomal inhi-
bition. The aminoglycosides are inhibitors
of translation, and they do not increase
global protein production. In both reporter
assays, we see induction of the reporter
gene by the inducing aminoglycosides;
i.e., we see increased protein production.
Furthermore, the three control drugs do
not cause induction of the reporter gene
through the same leader RNA, suggesting
that the induction that we observed was
genuine. Nor do we observe induction of
reporter genes for the control cat-86
leader RNA, suggesting that the induction
that we measure is specific for the
aac/aad leader RNA. We also observe
aminoglycoside-dependent induction of
reporter gene expression in cells in which
ribosomes were methylated (to block
aminoglycoside binding); therefore, the
induction that we see is independent of
aminoglycoside binding to ribosomes
and cannot be explained by antibiotic-
ribosome binding, as stated by Roth and
Breaker.
Roth and Breaker propose that the
aminoglycoside-dependent induction of
gene expression that we measure is com-
parable with an investigation on the
translational function of attI1 site-specific
integron sequences (Hanau-Berc¸ot et al.,
2002; Jacquier et al., 2009). Although
nucleotides 1–39 of the leader RNA of
aac/aad from Pseudomonas fluorescens
are the same as in Citrobacter freundii,
the remaining sequence differs. The
minimal functional aminoglycoside-
sensing RNA that we identified is 75
nucleotides (nt). There is, however, a
very important difference between the
two studies: we measure induction of
reporter gene expression in the pre-
sence of added aminoglycoside, whereas
Hanau-Berc¸ot and colleagues measured
steady-state translation in the absence3, June 20, 2013 ª2013 Elsevier Inc. 1419
of any drug. This is a significant difference
because our main purpose was to under-
stand how aminoglycosides induce acc/
aad gene expression. These studies are
therefore not directly comparable.
To investigate the role of the leader
peptide in the induction of gene expres-
sion, we made three mutations (M23–25)
in which the leader RNA sequence was
altered but the amino acid sequence of
the leader peptide was retained. M23–25
greatly reduced the induction of the re-
porter gene. Roth and Breaker propose
that, in M23–25, a point mutation (C11A)
outside of the peptide-coding sequence
introduces the sequence AAAGA, which
could act as a decoy SD sequence to
disrupt gene expression. This C11Amuta-
tion was introduced to destabilize a
potential competing RNA structure. To
test the function of this proposed decoy
SD sequence, we repaired the mutation
(C11A) to the wild-type RNA and made
new mutant constructs M23*–5*. We
found that M23*–5*, which do not contain
the proposed decoy SD sequence, also
greatly reduce the induction of the re-
porter gene and have the same pheno-
type as M23–25 (Figure S1 available
online). There is, therefore, no evidence
for a decoy SD sequence, as proposed
by Roth and Breaker, and our original
conclusion on the role of leader peptide
is confirmed. Mutant M4 that lacks the
C11A mutation also supports this conclu-
sion. The induction of the reporter gene by
aminoglycosides does not depend on
leader peptide expression.
The aminoglycoside-sensing RNA that
we have characterized contains an RNA
fragment that overlaps a DNA sequence
containing a strong promoter, the con-
served 50 attI1 site of a class 1 integron,
and extends beyond it to the neighboring
gene. Although we noted the association
with the integron cassette system in the
Results and Discussion sections, we did
not discuss this in depth because we re-
garded the relationship between a site-
specific DNA recombination system and
our regulatory RNA as beyond the scope
of the paper.1420 Cell 153, June 20, 2013 ª2013 ElsevierRoth and Breaker then argue that,
because the attI1 site functions as a
specific recombination site in DNA, it is
inconsistent with a regulatory role for the
corresponding RNA. We emphasize that
the leader RNA we studied is indeed
the 50 UTR of the aac/aad gene of
Pseudomonas fluorescens, although the
corresponding DNA sequence contains
the attI1 site (Hanau-Berc¸ot et al., 2002).
We defined the minimal functional unit of
the aminoglycoside-sensing RNA as 75
nt in length, which contains other impor-
tant sequences (SD2 and anti-SD) in addi-
tion to the attI1 site. The RNA sequence
that corresponds to the attI1 site alone
may not function as a riboswitch on its
own. Furthermore, blast analysis indi-
cates that sequences related to the aac/
aad leader RNA are predominately asso-
ciated with AAC or AAD resistance pro-
teins in class 1 integrons. Integrons are
known to be inseparable from antibiotic
resistance. The association of an antibi-
otic resistance gene with a site-specific
recombination site would confer a selec-
tive advantage to the integron in an
antibiotic-rich environment. A concurrent
inducible riboswitch that responds to a
commonly used antibiotic would there-
fore give an additional selective advan-
tage to the integron cassette.
Roth and Breaker note that other
aminoglycoside resistance genes (Table
S1A) are not associated with attI1 sites,
but this is because resistance to amino-
glycosides can be conferred by diverse
biochemical mechanisms (inactivation,
efflux, or rRNA methylation), and there is
no reason to expect a common riboswitch
mechanism for their control.
Resistance to antibiotics has emerged
over the last 60 or so years in response
toahighly selectiveantibiotic-richenviron-
ment. It hasbecomeamajor clinical threat,
andanunderstandingof themechanismof
resistance is critical. In our view, our data
demonstrate an aminoglycoside-sensing
RNA that regulates an aminoglyco-
side antibiotic-resistant gene. We thank
Drs. Roth and Breaker for discussion and
the further opportunity to clarify our data.Inc.SUPPLEMENTAL INFORMATION
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